Care
Mother and child

Where patients, partners, and quality matter

For over 75 years, Lannett has been proudly providing high-quality, affordable generic pharmaceutical products to patients who depend on them.

Learn More

h

Patient Support

We manufacture over 100 unique pharmaceutical product families for a wide range of therapeutic areas, with many more in development. Our philosophy? Patients first.

Learn More

h

Our Approach

Many of our patients will never know they are taking one of our medicines. But we know. That’s why we strive for the highest quality standards in our pharmaceutical products.

Learn More

h

Careers

Our culture combines a legacy of quality with an appetite for innovation. We’re looking for motivated, engaged individuals to help make the medicines that save and enhance lives.

Learn More

h

Spotlight

August 3, 2020

Lannett Announces Launch Of FDA Approved Levothyroxine Tablets

Lannett Company, Inc. (NYSE: LCI) today announced the launch of Cediprof, Inc.’s FDA approved Levothyroxine Sodium Tablets USP, under the companies’ recently announced interim exclusive supply and distribution agreement. The companies also said they have prevailed in separate legal challenges by Cediprof’s previous distributor of the product. Judges in two courts denied a request by the previous distribution partner for a temporary restraining order that sought to enjoin Cediprof from terminating the prior agreement and transferring distribution rights to Lannett.

Learn More